S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
First tracked pre-IPO filing for this issuer.
Exchange-Traded Fund Shares · Exchange Exchange · Ticker TINJ · Use of proceeds To purchase INJ at or immediately prior to the listing of the Shares on the Exchange · Flags foreign_private_issuer · Underwriters 21Shares US LLC
The 21Shares Injective ETF's S-1/A filing provides detailed procedures for the creation and redemption of Baskets, outlining roles for Authorized Participants, the Transfer Agent, INJ Custodians, and the Sponsor. It describes cash and in-kind transaction processes, settlement timelines, and responsibilities for parties involved. The filing emphasizes operational risks related to custodian services, price volatility from stablecoins, and regulatory uncertainties affecting the Injective Network.
2026-09-18 · 0001213900-26-101489
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
First tracked pre-IPO filing for this issuer.
Exchange-Traded Fund (ETF) common shares of beneficial interest · Exchange [●] · Baskets of [●] Shares · Use of proceeds To track the performance of INJ tokens and pay expenses · Flags units
21Shares Injective ETF (the Trust) is a passive exchange-traded fund designed to track the performance of INJ tokens, the native digital asset of the Injective blockchain. The Trust will hold INJ and value its shares daily based on the CME CF Injective-Dollar US Settlement Price, adjusted for expenses and staking rewards. The Sponsor, 21Shares US LLC, oversees the Trust, with CSC Delaware Trust Company as Trustee and Coinbase Custody and BitGo as INJ custodians. The ETF is not an investment company under the 1940 Act, lacking regulatory protections for investors. The Trust may engage third-party staking services, but staking decisions are subject to legal and tax risk assessments.
2025-10-20 · 0001213900-25-100111